S

Senseonics Holdings Inc
F:6L6

Watchlist Manager
Senseonics Holdings Inc
F:6L6
Watchlist
Price: 5 EUR -8.26% Market Closed
Market Cap: 2.7B EUR

Operating Margin

-210.5%
Current
Improving
by 125.9%
vs 3-y average of -336.4%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-210.5%
=
Operating Income
$-61.7m
/
Revenue
$29.3m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-210.5%
=
Operating Income
€-61.7m
/
Revenue
$29.3m

Peer Comparison

Country Company Market Cap Operating
Margin
US
Senseonics Holdings Inc
AMEX:SENS
295.1m USD
Loading...
US
Abbott Laboratories
NYSE:ABT
209.9B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
187.7B USD
Loading...
US
Stryker Corp
NYSE:SYK
138.8B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
135.9B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
128.6B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
58.8B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
48.7B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.7B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
49.4B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.8B USD
Loading...
No Stocks Found

Market Distribution

Lower than 88% of companies in the United States of America
Percentile
12th
Based on 14 112 companies
12th percentile
-210.5%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Senseonics Holdings Inc
Glance View

Market Cap
2.7B EUR
Industry
Health Care

Senseonics Holdings, Inc. engages in the design, development, and commercialization of an implantable continuous glucose monitoring system for people with diabetes. The company is headquartered in Germantown, Maryland and currently employs 121 full-time employees. The company went IPO on 2015-03-04. The firm is focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community. Its Eversense, Eversense XL, and Eversense E3 continuous glucose monitoring (CGM) systems are designed to continually measure glucose levels in people with diabetes via an under-the-skin sensor, a removable and rechargeable smart transmitter, and a mobile application for real-time diabetes monitoring and management for a period of up to six months. The company is also developing its Gemini product variation to allow for a two-in-one glucose monitoring system combining the functionality of CGM and Flash Glucose Monitoring (FGM), in an implantable sensor that may be utilized with a smart transmitter to get continuous glucose readings and alerts or be utilized through a swipe over the sensor with a smart phone to get on-demand glucose readings without a smart transmitter.

6L6 Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-210.5%
=
Operating Income
$-61.7m
/
Revenue
$29.3m
What is Senseonics Holdings Inc's current Operating Margin?

The current Operating Margin for Senseonics Holdings Inc is -210.5%, which is above its 3-year median of -336.4%.

How has Operating Margin changed over time?

Over the last 3 years, Senseonics Holdings Inc’s Operating Margin has increased from -429.7% to -210.5%. During this period, it reached a low of -429.7% on Aug 30, 2022 and a high of -210.5% on Oct 30, 2025.

Back to Top